• 1.

    Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 2021; 100:S1S276. doi: 10.1016/j.kint.2021.05.021

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Hou FF, et al.; for the MAIN Trial Investigators. Effectiveness of mycophenolate mofetil among patients with progressive IgA nephropathy: A randomized clinical trial. JAMA Netw Open 2023; 6:e2254054. doi: 10.1001/jamanetworkopen.2022.54054

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Hou JH, et al. Mycophenolate mofetil combined with prednisone versus full-dose prednisone in IgA nephropathy with active proliferative lesions: A randomized controlled trial. Am J Kidney Dis 2017; 69:788795. doi: 10.1053/j.ajkd.2016.11.027

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Chen X, et al. [A randomized control trial of mycophenolate mofetil treatment in severe IgA nephropathy.] Zhonghua Yi Xue Za Zhi 2002; 82:796801. PMID: 12126522; https://pubmed.ncbi.nlm.nih.gov/12126522/

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Maes BD, et al. Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study. Kidney Int 2004; 65:18421849. doi: 10.1111/j.1523-1755.2004.00588.x

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Frisch G, et al. Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: A double-blind randomized controlled trial. Nephrol Dial Transplant 2005; 20:21392145. doi: 10.1093/ndt/gfh974

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Tang SCW, et al. Long-term study of mycophenolate mofetil treatment in IgA nephropathy. Kidney Int 2010; 77:543549. doi: 10.1038/ki.2009.499

  • 8.

    Lv J, et al.; TESTING Study Group. Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: The TESTING randomized clinical trial. JAMA 2022; 327:18881898. doi: 10.1001/jama.2022.5368

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Dooley MA, et al.; ALMS Group. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 2011; 365:18861895. doi: 10.1056/NEJMoa1014460

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Werth VP, et al.; PEMPHIX Study Group. Rituximab versus mycophenolate mofetil in patients with pemphigus vulgaris. N Engl J Med 2021; 384:22952305. doi: 10.1056/NEJMoa2028564

    • PubMed
    • Search Google Scholar
    • Export Citation

Mycophenolate Mofetil for IgA Nephropathy: Yes or No?

Sahibzadi Mahrukh Noor Sahibzadi Mahrukh Noor, MD, and Sayna Norouzi, MD, are with the Department of Nephrology, Loma Linda University, Loma Linda, CA.

Search for other papers by Sahibzadi Mahrukh Noor in
Current site
Google Scholar
PubMed
Close
and
Sayna Norouzi Sahibzadi Mahrukh Noor, MD, and Sayna Norouzi, MD, are with the Department of Nephrology, Loma Linda University, Loma Linda, CA.

Search for other papers by Sayna Norouzi in
Current site
Google Scholar
PubMed
Close
Restricted access
Save